Circadian Rhythm Sleep Disorders Herbert Yue, MD Stanford - PowerPoint PPT Presentation

1 / 48
About This Presentation
Title:

Circadian Rhythm Sleep Disorders Herbert Yue, MD Stanford

Description:

Circadian Rhythm Sleep Disorders Herbert Yue, MD Stanford Sleep Medicine Center * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * Advanced Sleep Phase ... – PowerPoint PPT presentation

Number of Views:709
Avg rating:3.0/5.0
Slides: 49
Provided by: stanfordE3
Category:

less

Transcript and Presenter's Notes

Title: Circadian Rhythm Sleep Disorders Herbert Yue, MD Stanford


1
Circadian Rhythm Sleep Disorders
  • Herbert Yue, MD
  • Stanford Sleep Medicine Center

2
Introduction
  • Two modular processes that govern sleep and
    wakefulness
  • Referred to as two process model of sleep wake
    regulation
  • Homeostatic drive for sleep
  • Intrinsic circadian rhythm
  • For each hour of wakefulness, homeostatic drive
    for sleep increases
  • Typically after 14-16 hours, sufficient
    homeostatic sleep drive is obtain

3
Introduction
  • Circadian rhythm important regulator of
    wakefulness
  • Allows synchronization of physiologic process to
    desired sleep wake cycle
  • Exerts active promotion of wakefulness

4
Introduction
5
Circadian Rhythm Biology
  • Circadian rhythms generated from superchiasmatic
    nucleus (SCN) of hypothalamus
  • Signals from SCN modulate daily rhythms in sleep
    and alertness
  • Core body temperature
  • Secretion of cortisol and melatonin
  • Intrinsic rhythm of clock slightly longer than 24
    hours
  • Synchronization occurs to 24hr schedule using
    external cues
  • Zeitgeibers Temporal timing signals, light
    exposure

6
Circadian Rhythm Biology
  • Photoreceptors in retina important signal
    collectors
  • Receptors discovered in cells of retina
  • Important for entrainment
  • Contain photopigment melanopsin
  • Most sensitive to blue wavelength of light

7
Circadian Rhythm Biology
8
Circadian Phase Markers
  • Active investigation into markers of circadian
    phase in humans
  • ?Clinical utility of markers
  • Two currently utilized markers
  • Core body temperature
  • Dim light melatonin measurement (DLMO)

9
Core Body temperature
  • Drop in temp associated with stability in sleep
  • Three dips in temp
  • 800pm-1200am
  • 300-500am
  • 100-400pm

10
Melatonin Secretion
  • Increase in levels around 800pm
  • Levels peak at approximately 300am and begin to
    decrease
  • Lowest levels just before awakening

11
Circadian Phase Markers
  • Measurement of markers difficult
  • Core body temperature altered by activity, food
    intake, and sleep
  • Melatonin secretion very sensitive to light
    exposure, needs to be obtained under dim light
    conditions
  • Dim light melatonin onset (DLMO)

12
Circadian Rhythm
  • Disruptions in the circadian rhythm physiology
    consequently can cause a number of circadian
    rhythm sleep disorders
  • Disorders can be secondary to external inference
    with sleep wake mechanism
  • Remainder of disorders are related to inherent
    disruption of the circadian rhythm

13
Classification
  • Six distinct circadian rhythm disorders
    recognized by the International Classification of
    Sleep Disorders (ICSD-2)
  • Essential feature Persistent/recurrent pattern
    of sleep disturbance
  • Alterations in circadian timekeeping system
  • Misalignment between internal circadian timing
    and exogenous influences

14
Classification
  • Diagnostic criteria require impairment
  • Social, occupational, etc
  • Phase tolerance may exist i.e. sleep not
    disrupted by sleep alignment
  • Diagnosis also must not be better explained by
    other sleep disorder
  • Unconventional sleep cycle ? CRSD
  • Persistent insomnia no matter timing of sleep
  • Congruence of sleep timing and circadian rhythm

15
Classification
  • Six distinct CRSDs
  • Delayed sleep phase disorder
  • Advanced sleep phase disorder
  • Jet lag type
  • Shift work type
  • Irregular sleep wake cycle disorder
  • Free running type
  • ICSD also recognizes CRSD NOS
  • Secondary to medical condition, etc

16
Prevalence
  • Exact prevalence not known, although high numbers
    if shift workers/travelers considered
  • One formal study using diagnostic criteria with
    epidemiologic sample looked at SWD
  • 30 of night workers and 26 of rotating workers
    met minimal criteria for SWD
  • Little data for other CRSDs

17
Common Themes
  • All dxs require 2 week actigraphy/sleep diary
  • Goal is to create congruence
  • Treatment
  • Light in AM backward shift and vice versa
  • Melatonin works in opposite manner from light
  • Light, exercise in periods of activity

18
Shift Work Disorder (SWD)
  • Minimal criteria for diagnosis
  • Work in shift work position, either night-shift
    or rotating shift for the past 2 weeks
  • Impairment in daytime functioning, typically
    insomnia or excessive daytime sleepiness, present
    for gt 1 month

19
Shift Work Disorder (SWD)
20
Shift Work Disorder (SWD)
21
Shift Work Disorder (SWD)
22
Shift Work Disorder (SWD)
  • Rotating shift workers show increased rates of
    impairment
  • gt30 of rotating shift workers with reported
    sleep latencies of greater than 30 minutes
    compared to 10 of night and day shift workers
  • Increased rates of absenteeism, accidents at work
    and poor job satisfaction

23
Shift Work Disorder (SWD)
  • Risk factors for SWD
  • Increasing age peak in sleep disturbances at age
    52 with decreases after age 62
  • Female gender women with less sleep on average
    then men and increase complaints
  • Intrinsic tolerance of individuals

24
Shift Work Disorder (SWD)
  • Non-pharmacologic treatment
  • Sleep hygiene
  • Scheduled naps
  • Assessment of work schedule
  • Exercise
  • Light exposure

25
Shift Work Disorder (SWD)
  • Pharmacologic treatments include
    modafinil/stimulants
  • Only modafinil or armodafinil currently FDA
    approved as tx for SWD
  • Improvements in self reported sleepiness,
    objective sleep latencies, and accident rates
  • Other stimulants, such as amphetamines not
    indicated
  • Rebound insomnia

26
Delayed Sleep Phase Disorder (DSPD)
  • Characterized as bedtimes that are 3-6 hours
    later than conventional times
  • Typically problems sleeping before 200am and
    waking up earlier than 1000am
  • Subjective sleepiness worst in the mornings, with
    highest levels of alertness during the late
    evening

27
Delayed Sleep Phase Disorder (DSPD)
  • Difficulty with sleep onset at desired time, but
    sleep once initiated is normal
  • Most common CRSD referral, although population
    data lacking
  • Population estimates of prevalence of 0.17
  • Prevalence increases to gt15 amongst adolescents
  • Positive family history

28
Delayed Sleep Phase Disorder (DSPD)
29
Delayed Sleep Phase Disorder (DSPD)
  • Most patients present for treatment as they are
    unable to conform to societal bed/wake times
  • Treatment primarily light exposure and melatonin
    administration

30
Delayed Sleep Phase Disorder (DSPD)
  • Bright light therapy generally given in the early
    morning for 1-2 hours
  • Induces phase shift backwards
  • Typically takes upwards of 2 weeks to see effects
  • Compliance often limited

31
Melatonin Secretion
32
Delayed Sleep Phase Disorder (DSPD)
  • Melatonin may also be given, typically 5-7 hours
    before the DLMO
  • DLMO typically occurs 2-3 hours before sleep
    onset in healthy individuals
  • Effects of melatonin may not be long lived
  • Some studies show reversion to DSPD after
    medication stopped

33
Advanced Sleep Phase Disorder (ASPD)
  • Habitual and undesired sleep/wake up times
    several hours earlier than desired
  • Sleep onset 600-900pm and wake up times
    200-500am
  • Symptoms of early morning awakenings, sleep
    maintenance problems, or excessive daytime
    sleepiness

34
Advanced Sleep Phase Disorder (ASPD)
  • Associated with increasing age
  • Non age associated cases rare
  • Prevalence approx 1 of middle aged adults
  • Genetic markers identified, ?autosomal dominant
    transmission
  • -Missense mutation in Period 2 gene

35
Advanced Sleep Phase Disorder (ASPD)
  • Treatment typically light exposure in early
    evening
  • Usually in the hours of 700-900pm
  • Delays DLMO
  • Compliance limited in the few studies performed
  • No current role for hypnotics or stimulants

36
Melatonin Secretion
37
Jet Lag Disorder (JLD)
  • Defined as disruption in sleep after travel
    across 2-3 time zones
  • Typically benign and self limited, although can
    be distressing to patients productivity
  • Circadian rhythm resets
  • Approx 90 minutes later for westward flights
  • 60 minutes earlier for eastward flights
  • Treatment typically involves
  • Light administration
  • Melatonin administration

38
Jet Lag Disorder (JLD)
  • Treatment with light or melatonin usually
    involves corresponding exposure
  • Light exposure
  • Maximize exposure in the morning for westward
    flights, exposure in evening for eastward flight
  • Melatonin admin
  • Most studies evaluated 5mg dose at bedtime,
    typically for eastward travel

39
Melatonin Secretion
40
Jet Lag Disorder (JLD)
  • Hypnotics
  • 3-4 day course of Ambien associated with improved
    sleep quality
  • Short acting hypnotic such as Sonata may be
    helpful for an overnight flight
  • Armodafanil
  • Recent data showing improved subjective alertness
    and reduced jet lag sx
  • Current pending application as FDA approved
    treatment for JLD

41
Free Running Disorder (FRD)
  • Characterized as gradual drift of major sleep
    period by 1-2 hours daily
  • If scheduled sleep/wake times attempted, pts
    report insomnia and excessive daytime sleepiness
  • Sx occur when non-entrained circadian rhythm out
    of phase with conventional sleep/wake times
  • Majority of cases in the blind
  • Lack of photic entrainment
  • Estimated 50 have free running disorder, 70
    with chronic sleep disturbances
  • Cases described for non-blind, usually after head
    trauma

42
Free Running Disorder (FRD)
43
Free Running Disorder (FRD)
  • Treatment in sighted individuals
  • Scheduled sleep and wake cycles
  • Timed bright light
  • Melatonin admin
  • Treatment in blind individuals
  • Regular work/sleep schedule? non photic cue
  • Melatonin admin (1 hr before bedtime)

44
Irregular Sleep Wake Disorder (ISWD)
  • Characterized as absence of clear circadian
    rhythm
  • Although total amount of sleep normal, sleep
    periods scattered throughout the day
  • Napping prevalent, with sleep episodes gt 3 per
    day
  • Rare condition
  • Likely secondary to primary disturbance of
    circadian rhythm
  • Lack of external time cues, such as light and
    activity
  • Seen most commonly in dementia, developmentally
    disabled children, and with severe brain trauma

45
Irregular Sleep Wake Disorder (ISWD)
46
Irregular Sleep Wake Disorder (ISWD)
  • Treatment primarily restoring external time cues
  • Scheduled social and physical activities
  • Timed bright light
  • Some role for hypnotics to improve sleep

47
Conclusion
  • CRSD occur secondary to incongruence of sleep
    time and circadian rhythm or intrinsic disruption
    in circadian rhythm
  • Light and melatonin are useful adjuncts in tx
  • Zeitgebers are critically important
  • Growing literature demonstrating genetic basis
    for these conditions

48
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com